Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control

Diabetologia

Volumn 53, Issue 10, 2010, Pages 2264-2265

  Schatz, H ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Glycaemic control; Insulin requirements; Metformin; Type 1 diabetes

Indexed keywords

BIGUANIDE DERIVATIVE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PLACEBO;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES CONTROL; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 77958068664     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1844-3     Document Type: Letter

References (4)

1. Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR (2010) The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia 53:809-820
2. Schatz H, Winkler G, Jonatha EM, Pfeiffer EF (1975) Studies on juvenile-type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Diabete Metab 1:211-220 3.
3. Rahbar S, Blumenfeld O, Ranney HM (1969) Studies of an unusual haemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 67:838-843
4. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. New Engl J Med 295:417-420